Quality improvements of antimicrobial prophylaxis in coronary artery bypass grafting

The Journal of Surgical Research
Tzong-Bor SunMing-Hwang Shyr

Abstract

Although the principles of antibiotics prophylaxis are well established, more than 60% of hospitals that joined the international quality indicator project failed to discontinue the use of prophylactic antibiotics within 24h after coronary artery bypass grafting (CABG). Our specific aims are to disseminate the gain obtained from breakthrough series model in knee arthroplasty and abdominal hysterectomy to increase the rate of prophylactic duration not longer than 24h in patients with CABG. The control and intervention groups enrolled 55 and 78 patients with CABG before and after the project. Measurements were prophylactic interval and duration, surgical site infection, hospital and antibiotics costs. Two strategies were developed. The key cardiac surgeon was invited to attend quality improvement activities. Knowledge and rationale of medical quality indicators would thus be communicated. Secondly, we proposed a regional symposium in which a level of competition was subconsciously established, and practitioners would present their level of compliance. Instances of prophylactic interval within 1h prior to incision were significantly increased from 66.7% to 97.4%. Rates of prophylactic duration less than 24h were significantly incr...Continue Reading

References

Aug 1, 1996·The Journal of Antimicrobial Chemotherapy·I C GyssensJ W van der Meer
Mar 18, 2000·Journal of Chemotherapy·A Novelli
Mar 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Farrin A ManianDiane Senkel
Apr 12, 2005·American Journal of Surgery·Dale W BratzlerUNKNOWN Surgical Infection Prevention Guideline Writers Workgroup
Jun 24, 2005·American Journal of Surgery·E Patchen DellingerJonathan R Sugarman
Mar 27, 2007·The Annals of Thoracic Surgery·Richard EngelmanUNKNOWN Workforce on Evidence-Based Medicine, Society of Thoracic Surgeons
May 22, 2007·The British Journal of Surgery·Y MohriUNKNOWN Mie Surgical Infection Research Group
Sep 26, 2007·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Denise HenryPriya Hirway
Nov 21, 2007·Current Problems in Surgery·Traci L HedrickRobert G Sawyer

❮ Previous
Next ❯

Citations

Nov 21, 2012·Journal of the American College of Surgeons·Carolyn NessimAndy Smith
Sep 18, 2013·Journal of the American College of Surgeons·Shauna M LevyLillian S Kao
Aug 14, 2015·The Journal of Antimicrobial Chemotherapy·Peter Davey
Jul 19, 2018·The Journal of Antimicrobial Chemotherapy·Fabiana LorencattoPeter Davey
Mar 29, 2019·Stem Cells Translational Medicine·Ida SkovrindDitte Caroline Andersen
Nov 9, 2019·JAMA Network Open·Courtney IeranoTrisha Peel
Mar 19, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Trisha N PeelDarshini Ayton
Feb 9, 2017·The Cochrane Database of Systematic Reviews·Peter DaveySusan Michie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.